Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

The tularaemia vaccine

¹Division of Microbiology, National Defence Research Establishment, Umeå, Sweden.

Journal of Chemical Technology and Biotechnology (Oxford, Oxfordshire : 1986)

|April 1, 1994

Summary

Live vaccination against tularaemia using Francisella tularensis LVS induces protective immunity. Cell-mediated immunity is crucial for protection, necessitating careful control of vaccine production processes to maintain immunogenicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prehospital Treatment With Dried Plasma in Patients With Major Bleeding-A Prospective Randomised Controlled Multicentre Trial: Statistical Analysis Protocol.

Acta anaesthesiologica Scandinavica·2025

Same author

Bleeding resuscitation in the ambulance service, an observational study of standard care in Sweden.

Scandinavian journal of trauma, resuscitation and emergency medicine·2025

Same author

Identification and subtyping of Francisella by pyrosequencing and signature matching of 16S rDNA fragments.

Letters in applied microbiology·2011

Same author

Cellular and molecular response of human macrophages exposed to Aggregatibacter actinomycetemcomitans leukotoxin.

Cell death & disease·2011

Same author

Aeromonas-Acanthamoeba interaction and early shift to a viable but nonculturable state of Aeromonas by Acanthamoeba.

Journal of applied microbiology·2008

Same author

Protease inhibitors, the responsible components for the serum-dependent enhancement of Actinobacillus actinomycetemcomitans leukotoxicity.

European journal of oral sciences·2001

Area of Science:

Immunology
Microbiology
Vaccinology

Background:

Tularaemia is a zoonotic disease caused by the bacterium Francisella tularensis.
Current vaccination strategies rely on live attenuated vaccines to induce protective immunity.
The live vaccine strain (F. tularensis LVS) provides partial protection, with cell-mediated immunity being essential.

Purpose of the Study:

To investigate the immune response to F. tularensis LVS vaccination.
To understand the role of cell-mediated immunity in protection against tularaemia.
To highlight the importance of process parameters in preserving vaccine immunogenicity.

Main Methods:

Review of existing literature on tularaemia and F. tularensis LVS vaccination.
Analysis of humoral and cell-mediated immune responses post-vaccination.
Discussion of the implications of unknown attenuation mechanisms.

Main Results:

F. tularensis LVS vaccination elicits both humoral and cell-mediated immunity.
Cell-mediated immunity is a prerequisite for protective immunity against tularaemia.
The genetic basis of F. tularensis LVS attenuation remains largely uncharacterized.

Conclusions:

Effective tularaemia vaccination with F. tularensis LVS requires robust cell-mediated immunity.
Optimizing manufacturing process parameters is critical for maintaining vaccine immunogenicity.
Further research into the genetic basis of attenuation could improve vaccine efficacy.

Related Experiment Videos